Journal of Medicinal Chemistry p. 11221 - 11249 (2018)
Update date:2022-08-15
Topics:
Rogacki, Maciej K.
Pitta, Eleni
Balabon, Olga
Huss, Sophie
Lopez-Roman, Eva Maria
Argyrou, Argyrides
Blanco-Ruano, Delia
Cacho, Monica
Vande Velde, Christophe M. L.
Augustyns, Koen
Ballell, Lluis
Barros, David
Bates, Robert H.
Cunningham, Fraser
Van Der Veken, Pieter
Tuberculosis is the leading cause of death worldwide from infectious diseases. With the development of drug-resistant strains of Mycobacterium tuberculosis, there is an acute need for new medicines with novel modes of action. Herein, we report the discovery and profiling of a novel hydantoin-based family of antimycobacterial inhibitors of the decaprenylphospho-β-d-ribofuranose 2-oxidase (DprE1). In this study, we have prepared a library of more than a 100 compounds and evaluated them for their biological and physicochemical properties. The series is characterized by high enzymatic and whole-cell activity, low cytotoxicity, and a good overall physicochemical profile. In addition, we show that the series acts via reversible inhibition of the DprE1 enzyme. Overall, the novel compound family forms an attractive base for progression to further stages of optimization and may provide a promising drug candidate in the future.
View MoreContact:+91 - 22 - 26355700
Address:17, Lotus Business Park, Andheri West
website:http://www.NEM.COM.CN
Contact:+86-393-4411771
Address:The west section of shengli Road,Puyang,Henan Province,China
website:http://www.win-winchemical.com
Contact:0086-577-64498589
Address:6F,No.396 Xingping Road,Longwan Industrial Zone
Beijing Green Guardee Technology CO,.LTD
Contact:+86-10-69706062
Address:F2 BLdj,5 No.37 Chaoqian Road
Contact:+852-8198 2399
Address:9E, Leapont Industrial Building, 18-28 Wo Liu Hang Road, Shatin, New Territories, Hong Kong
Doi:10.1002/adsc.202000260
(2020)Doi:10.1021/cm200356y
(2011)Doi:10.1016/S0040-4039(00)89747-6
(1968)Doi:10.1039/c7cc08709h
(2018)Doi:10.1016/j.tet.2004.03.085
(2004)Doi:10.1016/j.bioorg.2019.01.039
(2019)